Dr. Lamba’s News Stories

These are links to recent news stories featuring Jatinder Lamba, Ph.D., and her research lab.

2020

Dr. Jatinder Lamba named 2020 UF Research Foundation Professor

2019

Dr. Jatinder Lamba receives a Live Like Bella grant to study pediatric cancer

Leukemia and Lymphoma Society awards grant to support pediatric cancer research

Dr. Jatinder Lamba’s lab receives multiple research accolades

UF Pharmacy wins four abstract awards at ASH Annual Meeting

2017

UF researchers identify gene variant to personalize therapy for deadly form of leukemia

Bringing a leukemia treatment back to life with precision medicine

Potential biomarker for acute myeloid leukaemia therapy

Anti-Leukemic Drug Gemtuzumab Ozogamicin May Benefit Some AML Patients

CD33 Splicing Polymorphism and Response to Gemtuzumab Ozogamicin in AML

2015

GatorX 2015

The promise of better therapy

To tailor cancer treatment: Study uses computer simulation to model patient cancer DNA

Online Publications:

CD33 directed therapy: Current and future perspective in acute myeloid leukemia (AML) (Sept. 2018)

Acute Myeloid Leukemia (AML) research and Application (April 20, 2018)

Acute Myeloid Leukemia and cytarabine pharmacogenomics (Feb 2, 2018)

Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML) (Nov.2017)

The Genetic Puzzle: Why Do We Respond to Cancer Therapy?

An interview and our research on pharmacogenomics in leukemia (Paths to Precise Prescriptions) was highlighted in International Innovations Journal.